AAIC 2025 Abstract
DIAN‐TU‐001 Trial (Tau NexGen) Rationale and Enrollment Experience
By Lon S. S. Schneider, Jorge J. Llibre-Guerra, David B. Clifford, Show 9 more authorsRandall John Bateman
Trial in peopleInterventions
Abstract
Background: Alzheimer's disease (AD) is characterized by the sequential but overlapping accumulations of amyloid‐beta plaques and tau neurofibrillary tangles prior to symptom onset.
